Why choose AMDL
Future Biotechnology Platform
Precision Diagnosis
Precision Treatment
With the state-of-the-art technologies, we can provide affordable genetic test services to the general publics. Our continuous R&D activities help to establish and implement cutting-edge genetic test services into our system. Most importantly, our well-trained professionals are all complied to CAP/CLIA standard to provide technical and bioinformatics support.
Discover the impact of mutations in human cancers
0
+
peer reviewed papers
Genome-wide Screen Data
0
+
genome screening data and other databases such as TCGA and ICGC *
0
+
Genomic variants
0
Total human samples
0
Peer reviewed papers
* Statistics is from COSMIC database https://cancer.sanger.ac.uk/cosmic/about
